• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清生物标志物和临床因素对相对健康的重症肺炎和急性呼吸窘迫综合征患者重症监护病房死亡率和 6 个月结局的影响。

Impact of serum biomarkers and clinical factors on intensive care unit mortality and 6-month outcome in relatively healthy patients with severe pneumonia and acute respiratory distress syndrome.

机构信息

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan ; Department of Respiratory Care, Chang Gung University of Science and Technology, Chiayi 813, Taiwan.

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan ; Department of Respiratory Care, Chang Gung University of Science and Technology, Chiayi 813, Taiwan ; Department of Respiratory Therapy, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan.

出版信息

Dis Markers. 2014;2014:804654. doi: 10.1155/2014/804654. Epub 2014 Mar 3.

DOI:10.1155/2014/804654
PMID:24723739
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3958786/
Abstract

OBJECTIVES

This study aimed to identify the independent biomarkers and clinical factors that could predict ICU mortality and 6-month outcomes in relatively healthy patients with severe pneumonia and acute respiratory distress syndrome (ARDS).

PATIENTS AND METHODS

We prospectively enrolled patients with severe pneumonia-related ARDS that required mechanical ventilation. Patients were excluded if they were unable to take care of themselves. Several biomarkers and clinical factors were evaluated prospectively on day 1 and day 3 after ICU admission. All biomarkers and clinical factors were collected for analysis.

RESULTS

56 patients were enrolled in this study. We determined that the initial appropriate antibiotics use was an independent clinical factor and day 1 high-mobility group protein B1 (HMGB1) concentration was an independent biomarker for ICU mortality. Interestingly, we also found that a low day 1 albumin level was an independent biomarker for predicting patient life dependence 6 months after a pneumonia event.

CONCLUSION

Patients with severe pneumonia and ARDS requiring mechanical ventilation experience high rates of ICU mortality or disability, even if they were quite healthy before. Initial appropriate antibiotics use and day 1 level of HMGB1 were independent factors for predicting ICU mortality. Day 1 albumin level was predictive of 6-month patient life dependence.

摘要

目的

本研究旨在确定能够预测相对健康的严重肺炎合并急性呼吸窘迫综合征(ARDS)患者 ICU 死亡率和 6 个月结局的独立生物标志物和临床因素。

患者和方法

我们前瞻性纳入需要机械通气的严重肺炎相关 ARDS 患者。排除无法自理的患者。在 ICU 入院后第 1 天和第 3 天,前瞻性评估了几种生物标志物和临床因素。所有生物标志物和临床因素均进行了分析。

结果

本研究共纳入 56 例患者。我们确定初始适当使用抗生素是一个独立的临床因素,第 1 天高迁移率族蛋白 B1(HMGB1)浓度是预测 ICU 死亡率的独立生物标志物。有趣的是,我们还发现,第 1 天白蛋白水平较低是预测肺炎事件 6 个月后患者生活依赖的独立生物标志物。

结论

即使在发病前相当健康,需要机械通气的严重肺炎合并 ARDS 患者 ICU 死亡率或残疾率仍较高。初始适当使用抗生素和第 1 天 HMGB1 水平是预测 ICU 死亡率的独立因素。第 1 天白蛋白水平可预测 6 个月患者的生活依赖。

相似文献

1
Impact of serum biomarkers and clinical factors on intensive care unit mortality and 6-month outcome in relatively healthy patients with severe pneumonia and acute respiratory distress syndrome.血清生物标志物和临床因素对相对健康的重症肺炎和急性呼吸窘迫综合征患者重症监护病房死亡率和 6 个月结局的影响。
Dis Markers. 2014;2014:804654. doi: 10.1155/2014/804654. Epub 2014 Mar 3.
2
Risk factor analysis of nosocomial lower respiratory tract infection in influenza-related acute respiratory distress syndrome.流感相关性急性呼吸窘迫综合征患者下呼吸道医院感染的危险因素分析。
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620942417. doi: 10.1177/1753466620942417.
3
Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries.全球 50 个国家重症监护病房急性呼吸窘迫综合征患者的流行病学、治疗模式和死亡率。
JAMA. 2016 Feb 23;315(8):788-800. doi: 10.1001/jama.2016.0291.
4
Galectin-3 as prognostic biomarker in patients with COVID-19 acute respiratory failure.半乳糖凝集素-3 作为 COVID-19 急性呼吸衰竭患者的预后生物标志物。
Respir Med. 2021 Oct;187:106556. doi: 10.1016/j.rmed.2021.106556. Epub 2021 Aug 4.
5
Serum soluble triggering receptor expressed on myeloid cells-1 in acute respiratory distress syndrome: a prospective observational cohort study.血清可溶性髓系细胞触发受体-1 在急性呼吸窘迫综合征中的作用:一项前瞻性观察性队列研究。
J Formos Med Assoc. 2010 Nov;109(11):800-9. doi: 10.1016/S0929-6646(10)60125-8.
6
Aetiology, outcomes & predictors of mortality in acute respiratory distress syndrome from a tertiary care centre in north India.印度北部一家三级护理中心急性呼吸窘迫综合征的病因、结局及死亡预测因素
Indian J Med Res. 2016 Jun;143(6):782-792. doi: 10.4103/0971-5916.192063.
7
[Quality of results of therapy of acute respiratory failure : changes over a period of two decades].[急性呼吸衰竭治疗结果的质量:二十年期间的变化]
Anaesthesist. 2013 Apr;62(4):261-70. doi: 10.1007/s00101-013-2156-z. Epub 2013 Apr 6.
8
Plasma kallistatin levels in patients with severe community-acquired pneumonia.重症社区获得性肺炎患者的血浆激肽释放酶抑制蛋白水平
Crit Care. 2013 Feb 8;17(1):R27. doi: 10.1186/cc12507.
9
Efficacy of intraoperative, single-bolus corticosteroid administration to prevent postoperative acute respiratory failure after oesophageal cancer surgery.术中单次大剂量给予皮质类固醇预防食管癌手术后急性呼吸衰竭的疗效
Interact Cardiovasc Thorac Surg. 2012 Oct;15(4):639-43. doi: 10.1093/icvts/ivs167. Epub 2012 Jun 28.
10
Patterns and Impact of Arterial CO Management in Patients With Acute Respiratory Distress Syndrome: Insights From the LUNG SAFE Study.急性呼吸窘迫综合征患者动脉血二氧化碳管理的模式和影响:来自 LUNG SAFE 研究的观察。
Chest. 2020 Nov;158(5):1967-1982. doi: 10.1016/j.chest.2020.05.605. Epub 2020 Jun 24.

引用本文的文献

1
Regulated cell death and DAMPs as biomarkers and therapeutic targets in normothermic perfusion of transplant organs. Part 2: implementation strategies.作为移植器官常温灌注生物标志物和治疗靶点的程序性细胞死亡和损伤相关分子模式。第2部分:实施策略。
Front Transplant. 2025 Apr 24;4:1575703. doi: 10.3389/frtra.2025.1575703. eCollection 2025.
2
Decreasing mRNA HMGB1 expression in infection treated by Miana ( (L.) Benth): a cohort experimental study.在绵毛鹿茸草(Miana (L.) Benth)治疗的感染中降低mRNA HMGB1表达:一项队列实验研究。
Ann Med Surg (Lond). 2023 May 23;85(6):2395-2399. doi: 10.1097/MS9.0000000000000908. eCollection 2023 Jun.
3

本文引用的文献

1
High Mobility Group Box-1 mediates hyperoxia-induced impairment of Pseudomonas aeruginosa clearance and inflammatory lung injury in mice.高迁移率族蛋白 B1 介导高氧诱导的铜绿假单胞菌清除障碍和小鼠肺部炎症损伤。
Am J Respir Cell Mol Biol. 2013 Mar;48(3):280-7. doi: 10.1165/rcmb.2012-0279OC. Epub 2012 Oct 18.
2
Plasma from septic shock patients induces loss of muscle protein.脓毒性休克患者的血浆会导致肌肉蛋白流失。
Crit Care. 2011;15(5):R233. doi: 10.1186/cc10475. Epub 2011 Sep 29.
3
Comparison of Charlson comorbidity index with SAPS and APACHE scores for prediction of mortality following intensive care.
Glycyrrhizin through liquorice intake modulates ACE2 and HMGB1 levels-A pilot study in healthy individuals with implications for COVID-19 and ARDS.
甘草酸通过摄入甘草调节 ACE2 和 HMGB1 水平-对 COVID-19 和 ARDS 患者的健康个体的初步研究。
PLoS One. 2022 Oct 17;17(10):e0275181. doi: 10.1371/journal.pone.0275181. eCollection 2022.
4
Evidence for Monocyte Reprogramming in a Long-Term Postsepsis Study.长期脓毒症后研究中单核细胞重编程的证据。
Crit Care Explor. 2022 Jul 29;4(8):e0734. doi: 10.1097/CCE.0000000000000734. eCollection 2022 Aug.
5
The HMGB1-RAGE axis induces apoptosis in acute respiratory distress syndrome through PERK/eIF2α/ATF4-mediated endoplasmic reticulum stress.高迁移率族蛋白 B1-晚期糖基化终末产物受体轴通过 PERK/eIF2α/ATF4 介导的内质网应激诱导急性呼吸窘迫综合征细胞凋亡。
Inflamm Res. 2022 Nov;71(10-11):1245-1260. doi: 10.1007/s00011-022-01613-y. Epub 2022 Jul 24.
6
HMGB1: A Potential Target of Nervus Vagus Stimulation in Pediatric SARS-CoV-2-Induced ALI/ARDS.高迁移率族蛋白B1:小儿严重急性呼吸综合征冠状病毒2诱导的急性肺损伤/急性呼吸窘迫综合征中迷走神经刺激的潜在靶点
Front Pediatr. 2022 May 11;10:884539. doi: 10.3389/fped.2022.884539. eCollection 2022.
7
Analysis of Early Biomarkers Associated with the Development of Critical Respiratory Failure in Coronavirus Disease 2019 (COVID-19).2019冠状病毒病(COVID-19)中与重症呼吸衰竭发生相关的早期生物标志物分析
Diagnostics (Basel). 2022 Jan 28;12(2):339. doi: 10.3390/diagnostics12020339.
8
Eosinophil Cell Count Predicts Mortality in the Intensive Care Unit after Return of Spontaneous Circulation.嗜酸性粒细胞计数可预测心脏骤停自主循环恢复后重症监护病房的死亡率。
Rambam Maimonides Med J. 2022 Jan 27;13(1):e0001. doi: 10.5041/RMMJ.10458.
9
Targeting Inflammasome Activation in COVID-19: Delivery of RNA Interference-Based Therapeutic Molecules.靶向新冠病毒感染中的炎性小体激活:基于RNA干扰的治疗性分子递送
Biomedicines. 2021 Dec 3;9(12):1823. doi: 10.3390/biomedicines9121823.
10
Role of Damage-Associated Molecular Patterns in Light of Modern Environmental Research: A Tautological Approach.从现代环境研究角度看损伤相关分子模式的作用:一种同义反复的方法。
Int J Environ Res. 2020;14(5):583-604. doi: 10.1007/s41742-020-00276-z. Epub 2020 Aug 9.
比较 Charlson 合并症指数与 SAPS 和 APACHE 评分对 ICU 后死亡率的预测
Clin Epidemiol. 2011;3:203-11. doi: 10.2147/CLEP.S20247. Epub 2011 Jun 17.
4
Functional disability 5 years after acute respiratory distress syndrome.急性呼吸窘迫综合征 5 年后的功能障碍。
N Engl J Med. 2011 Apr 7;364(14):1293-304. doi: 10.1056/NEJMoa1011802.
5
Long-term outcomes in patients surviving acute respiratory distress syndrome.急性呼吸窘迫综合征存活患者的长期结局。
Semin Respir Crit Care Med. 2010 Feb;31(1):55-65. doi: 10.1055/s-0029-1246285. Epub 2010 Jan 25.
6
Bench-to-bedside review: Appropriate antibiotic therapy in severe sepsis and septic shock--does the dose matter?从 bench 到床边的综述:严重脓毒症和脓毒性休克中的适当抗生素治疗——剂量重要吗?
Crit Care. 2009;13(3):214. doi: 10.1186/cc7774. Epub 2009 Jun 10.
7
Estimating long-term survival of critically ill patients: the PREDICT model.评估重症患者的长期生存率:PREDICT模型。
PLoS One. 2008 Sep 17;3(9):e3226. doi: 10.1371/journal.pone.0003226.
8
HMGB1: endogenous danger signaling.高迁移率族蛋白B1:内源性危险信号
Mol Med. 2008 Jul-Aug;14(7-8):476-84. doi: 10.2119/2008-00034.Klune.
9
Appropriate vs. inappropriate antimicrobial therapy.适当与不适当的抗菌治疗。
Clin Microbiol Infect. 2008 Apr;14 Suppl 3:15-21. doi: 10.1111/j.1469-0691.2008.01959.x.
10
HMGB1 as a predictor of organ dysfunction and outcome in patients with severe sepsis.高迁移率族蛋白B1作为严重脓毒症患者器官功能障碍和预后的预测指标
Intensive Care Med. 2008 Jun;34(6):1046-53. doi: 10.1007/s00134-008-1032-9. Epub 2008 Feb 23.